These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 3137310)

  • 1. [The Recklinghausen model: innumerable phenotypes and scarce genotypes].
    Robert JM
    J Genet Hum; 1988 Jun; 36(3):147-61. PubMed ID: 3137310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the gene for von Recklinghausen neurofibromatosis somatically unstable?
    Schaible RH
    Neurofibromatosis; 1989; 2(3):138-51. PubMed ID: 2517528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic alterations and growth factors in the pathogenesis of von Recklinghausen neurofibromatosis.
    Riccardi VM
    Neurofibromatosis; 1989; 2(5-6):292-8. PubMed ID: 2562041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exclusion of allelism of Noonan syndrome and neurofibromatosis-type 1 in a large family with Noonan syndrome-neurofibromatosis association.
    Bahuau M; Flintoff W; Assouline B; Lyonnet S; Le Merrer M; Prieur M; Guilloud-Bataille M; Feingold N; Munnich A; Vidaud M; Vidaud D
    Am J Med Genet; 1996 Dec; 66(3):347-55. PubMed ID: 8985499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Von Recklinghausen disease: contributions of genetics and molecular biology].
    Plauchu H
    Pediatrie; 1992; 47(6):423-5. PubMed ID: 1331958
    [No Abstract]   [Full Text] [Related]  

  • 6. Neurofibromatosis (von Recklinghausen disease). Genetics, cell biology, and biochemistry.
    Adv Neurol; 1981; 29():1-282. PubMed ID: 6798830
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutations in von Recklinghausen neurofibromatosis: an hypothesis.
    Zlotogora J
    Am J Med Genet; 1993 Apr; 46(2):182-4. PubMed ID: 8484407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Malignant transformation of Recklinghausen disease in the small intestine].
    Khalil MR
    Ugeskr Laeger; 1998 Sep; 160(38):5517-8. PubMed ID: 9763929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurofibromatosis type 1.
    Legius E; Descheemaeker MJ; Fryns JP; Van den Berghe H
    Genet Couns; 1994; 5(3):225-41. PubMed ID: 7811422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?
    Kehrer-Sawatzki H; Cooper DN
    J Med Genet; 2008 Oct; 45(10):622-31. PubMed ID: 18511569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour suppressor genes, immunology and local manifestations of neurofibromatosis phenotypes.
    Gerosa PL; Spinelli M; Iannarelli S; Giussani G; Canepari C; Fontana A; Vai C; Bizzozero L
    Panminerva Med; 1996 Sep; 38(3):157-63. PubMed ID: 9009679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From the clinic to the research laboratory. The role of the clinician in molecular genetic studies.
    Palmer SE; Stephens K
    Arch Dermatol; 1993 Nov; 129(11):1424-9. PubMed ID: 8239701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probable clonal origin of neurofibrosarcoma in a patient with hereditary neurofibromatosis.
    Friedman JM; Fialkow PJ; Greene CL; Weinberg MN
    J Natl Cancer Inst; 1982 Dec; 69(6):1289-92. PubMed ID: 6815362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
    Sabol Z; Kipke-Sabol L
    Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of extreme phenotype selection studies in the identification of clinically relevant genotypes in cancer research.
    Perez-Gracia JL; Gloria Ruiz-Ilundain M; Garcia-Ribas I; Maria Carrasco E
    Cancer; 2002 Oct; 95(7):1605-10. PubMed ID: 12237932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Case report of familial generalized neurofibromatosis (von Recklinghausen disease)].
    Stojanović S; Poljacki M; Stanojević Z
    Med Pregl; 1993; 46(11-12):413-6. PubMed ID: 7997195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant transformation in Von Recklinghausen's disease. Apropos of 2 cases].
    Gombe Mbalawa C; Mobengo P
    Sem Hop; 1984 May; 60(19):1357-60. PubMed ID: 6326328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetics: toward an understanding of childhood cancer.
    Kreissman SG
    Semin Pediatr Surg; 1993 Feb; 2(1):2-10. PubMed ID: 8062019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mild mutator phenotype arises in a mouse model for malignancies associated with neurofibromatosis type 1.
    Garza R; Hudson RA; McMahan CA; Walter CA; Vogel KS
    Mutat Res; 2007 Feb; 615(1-2):98-110. PubMed ID: 17208258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.